| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |